SEC Form SC 13G filed by Hyperfine Inc.

2/14/22 11:18:38 AM ET

$HYPR

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Health Care

Get the next $HYPR alert in real time by email

SC 13G 1 tm226422d1_sc13g.htm SC 13G

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. )*

Hyperfine, Inc.
(Name of Issuer)

Class A common stock
(Title of Class of Securities)

44916K106
(CUSIP Number)

December 31, 2021
(Date of Event Which Requires Filing of this Statement)

Check the Appropriate Box to Designate the Rule Pursuant to Which this Schedule Is Filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

1.	Names of Reporting Persons HC Sponsor LLC
2.	Check The Appropriate Box if a Member of a Group (See Instructions) (a) ¨         (b) ¨
3.	SEC Use Only
4.	Citizenship or Place of Organization Cayman Islands

Number of Shares Beneficially Owned By Each Reporting Person With	5.	Sole Voting Power 0
	6.	Shared Voting Power 6,534,000⁽¹⁾
	7.	Sole Dispositive Power 0
	8.	Shared Dispositive Power 6,534,000⁽¹⁾

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 6,534,000⁽¹⁾
10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares	¨
11.	Percent of Class Represented By Amount in Row (9) 11.8%⁽²⁾
12.	Type of Reporting Person (See Instructions) OO

(1) Represents 5,534,000 Class A Shares held directly by HC Sponsor LLC and 1,000,000 Class A Shares held directly by the HC Affiliates.

(2) Calculated based on 55,277,061 Class A Shares outstanding as of December 31, 2021, as reported on the Issuer’s final prospectus filed pursuant to Rule 424(b)(3) with the SEC on February 1, 2022.

1.	Names of Reporting Persons HealthCor Group, LLC
2.	Check The Appropriate Box if a Member of a Group (See Instructions) (a) ¨         (b) ¨
3.	SEC Use Only
4.	Citizenship or Place of Organization New York

Number of Shares Beneficially Owned By Each Reporting Person With	5.	Sole Voting Power 0
	6.	Shared Voting Power 6,534,000⁽¹⁾
	7.	Sole Dispositive Power 0
	8.	Shared Dispositive Power 6,534,000⁽¹⁾

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 6,534,000⁽¹⁾
10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares	¨
11.	Percent of Class Represented By Amount in Row (9) 11.8%⁽²⁾
12.	Type of Reporting Person (See Instructions) OO

(1) Represents 5,534,000 Class A Shares held directly by HC Sponsor LLC and 1,000,000 Class A Shares held directly by the HC Affiliates.

1.	Names of Reporting Persons Arthur Bruce Cohen
2.	Check The Appropriate Box if a Member of a Group (See Instructions) (a) ¨         (b) ¨
3.	SEC Use Only
4.	Citizenship or Place of Organization United States

Number of Shares Beneficially Owned By Each Reporting Person With	5.	Sole Voting Power 0
	6.	Shared Voting Power 6,534,000⁽¹⁾
	7.	Sole Dispositive Power 0
	8.	Shared Dispositive Power 6,534,000⁽¹⁾

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 6,534,000⁽¹⁾
10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares	¨
11.	Percent of Class Represented By Amount in Row (9) 11.8%⁽²⁾
12.	Type of Reporting Person (See Instructions) IN

(1) Represents 5,534,000 Class A Shares held directly by HC Sponsor LLC and 1,000,000 Class A Shares held directly by the HC Affiliates.

1.	Names of Reporting Persons Joseph Patrick Healey
2.	Check The Appropriate Box if a Member of a Group (See Instructions) (a) ¨         (b) ¨
3.	SEC Use Only
4.	Citizenship or Place of Organization United States

Number of Shares Beneficially Owned By Each Reporting Person With	5.	Sole Voting Power 0
	6.	Shared Voting Power 6,534,000⁽¹⁾
	7.	Sole Dispositive Power 0
	8.	Shared Dispositive Power 6,534,000⁽¹⁾

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 6,534,000⁽¹⁾
10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares	¨
11.	Percent of Class Represented By Amount in Row (9) 11.8%⁽²⁾
12.	Type of Reporting Person (See Instructions) IN

(1) Represents 5,534,000 Class A Shares held directly by HC Sponsor LLC and 1,000,000 Class A Shares held directly by the HC Affiliates.

Item 1(a).	Name of Issuer
	Hyperfine, Inc.
Item 1(b).	Address of the Issuer’s Principal Executive Offices
	351 New Whitfield Street Guilford, CT 06437
Item 2(a).	Names of Persons Filing
	This statement is filed on behalf of each of the following persons (collectively, the “Reporting Persons”): (i) HC Sponsor LLC (ii) HealthCor Group, LLC (iii) Arthur Bruce Cohen (iv) Joseph Patrick Healey
Item 2(b).	Address of the Principal Business Office, or if none, Residence:
	55 Hudson Yards, 28th Floor New York, NY 10001
Item 2(c).	Citizenship
	See responses to Item 4 on each cover page.
Item 2(d).	Title of Class of Securities
	Class A common stock
Item 2(e).	CUSIP Number
	44916K106
Item 3.	If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a(n):
	Not Applicable.

Item 4.

Ownership

(a) Amount beneficially owned:

See responses to Item 9 on each cover page.

(b) Percent of Class:
See responses to Item 11 on each cover page.

(c) Number of shares as to which the Reporting Person has:

(i) Sole power to vote or to direct the vote:

See responses to Item 5 on each cover page.

(ii) Shared power to vote or to direct the vote:

See responses to Item 6 on each cover page.

(iii) Sole power to dispose or to direct the disposition of:

See responses to Item 7 on each cover page.

(iv) Shared power to dispose or to direct the disposition of:

See responses to Item 8 on each cover page.

	HC Sponsor LLC (the “Sponsor”) directly holds 5,534,000 Class A Shares (the “Founder Shares”) and entities affiliated with the Sponsor (the “HC Affiliates”) directly hold 1,000,000 Class A Shares (the “PIPE Shares”). The Sponsor is managed by its manager, HealthCor Sponsor Investments LLC, which is managed by its manager, HealthCor Group, LLC, which also indirectly manages the HC Affiliates. Arthur Cohen and Joseph Healey are the controlling members of HealthCor Group, LLC. As such, Messrs. Cohen and Healey have voting and investment discretion with respect to the securities held by each of HC Sponsor LLC and the HC Affiliates but disclaim beneficial ownership of such securities. The filing of this Statement shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any securities covered by this Statement.
Item 5.	Ownership of Five Percent or Less of a Class
	Not Applicable.
Item 6.	Ownership of More than Five Percent on Behalf of Another Person
	Not Applicable.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company
	Not Applicable.
Item 8.	Identification and Classification of Members of the Group
	Not Applicable.
Item 9.	Notice of Dissolution of Group
	Not Applicable.
Item 10.	Certification
	Not Applicable.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 14, 2022

	HC Sponsor LLC

	By:	/s/ Christine Clarke
	Name:	Christine Clarke
	Title:	Authorized Signatory

	HealthCor Group, LLC

	By:	/s/ Christine Clarke
	Name:	Christine Clarke
	Title:	Authorized Signatory

	/s/ Arthur B. Cohen
	Arthur B. Cohen

	/s/ Joseph P. Healey
	Joseph P. Healey

EXHIBIT INDEX

Exhibit No.		Description
99.1		Joint Filing Agreement, dated as of February 14, 2022 by and among HC Sponsor LLC, HealthCor Group, LLC, Arthur B. Cohen and Joseph P. Healey

Exhibit 99.1

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Class A common stock, $0.0001 par value per share, of Hyperfine, Inc., and further agree that this Joint Filing Agreement shall be included as an exhibit to such joint filings.

The undersigned further agree that each party hereto is responsible for the timely filing of such Statement on Schedule 13G and any amendments thereto, and for the accuracy and completeness of the information concerning such party contained therein; provided, however, that no party is responsible for the accuracy or completeness of the information concerning any other party, unless such party knows or has reason to believe that such information is inaccurate.

This Joint Filing Agreement may be signed in counterparts with the same effect as if the signature on each counterpart were upon the same instrument.

	HC Sponsor LLC

	By:	/s/ Christine Clarke
	Name:	Christine Clarke
	Title:	Authorized Signatory

	HealthCor Group, LLC

	By:	/s/ Christine Clarke
	Name:	Christine Clarke
	Title:	Authorized Signatory

	/s/ Arthur B. Cohen
	Arthur B. Cohen

	/s/ Joseph P. Healey
	Joseph P. Healey

Get the next $HYPR alert in real time by email

Date

Price Target

Rating

Analyst

8/11/2022

$8.00 → $2.40

Overweight → Equal Weight

Wells Fargo

5/31/2022

$7.00

Outperform

Evercore ISI

4/14/2022

$8.00

Overweight

Wells Fargo

SEC Form SC 13G filed by Hyperfine Inc.

2/14/22 11:18:38 AM ET

$HYPR

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Health Care

Get the next $HYPR alert in real time by email

SC 13G 1 tm226422d1_sc13g.htm SC 13G

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. )*

Hyperfine, Inc.
(Name of Issuer)

Class A common stock
(Title of Class of Securities)

44916K106
(CUSIP Number)

December 31, 2021
(Date of Event Which Requires Filing of this Statement)

Check the Appropriate Box to Designate the Rule Pursuant to Which this Schedule Is Filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

1.	Names of Reporting Persons HC Sponsor LLC
2.	Check The Appropriate Box if a Member of a Group (See Instructions) (a) ¨         (b) ¨
3.	SEC Use Only
4.	Citizenship or Place of Organization Cayman Islands

Number of Shares Beneficially Owned By Each Reporting Person With	5.	Sole Voting Power 0
	6.	Shared Voting Power 6,534,000⁽¹⁾
	7.	Sole Dispositive Power 0
	8.	Shared Dispositive Power 6,534,000⁽¹⁾

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 6,534,000⁽¹⁾
10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares	¨
11.	Percent of Class Represented By Amount in Row (9) 11.8%⁽²⁾
12.	Type of Reporting Person (See Instructions) OO

(1) Represents 5,534,000 Class A Shares held directly by HC Sponsor LLC and 1,000,000 Class A Shares held directly by the HC Affiliates.

1.	Names of Reporting Persons HealthCor Group, LLC
2.	Check The Appropriate Box if a Member of a Group (See Instructions) (a) ¨         (b) ¨
3.	SEC Use Only
4.	Citizenship or Place of Organization New York

Number of Shares Beneficially Owned By Each Reporting Person With	5.	Sole Voting Power 0
	6.	Shared Voting Power 6,534,000⁽¹⁾
	7.	Sole Dispositive Power 0
	8.	Shared Dispositive Power 6,534,000⁽¹⁾

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 6,534,000⁽¹⁾
10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares	¨
11.	Percent of Class Represented By Amount in Row (9) 11.8%⁽²⁾
12.	Type of Reporting Person (See Instructions) OO

(1) Represents 5,534,000 Class A Shares held directly by HC Sponsor LLC and 1,000,000 Class A Shares held directly by the HC Affiliates.

1.	Names of Reporting Persons Arthur Bruce Cohen
2.	Check The Appropriate Box if a Member of a Group (See Instructions) (a) ¨         (b) ¨
3.	SEC Use Only
4.	Citizenship or Place of Organization United States

Number of Shares Beneficially Owned By Each Reporting Person With	5.	Sole Voting Power 0
	6.	Shared Voting Power 6,534,000⁽¹⁾
	7.	Sole Dispositive Power 0
	8.	Shared Dispositive Power 6,534,000⁽¹⁾

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 6,534,000⁽¹⁾
10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares	¨
11.	Percent of Class Represented By Amount in Row (9) 11.8%⁽²⁾
12.	Type of Reporting Person (See Instructions) IN

(1) Represents 5,534,000 Class A Shares held directly by HC Sponsor LLC and 1,000,000 Class A Shares held directly by the HC Affiliates.

1.	Names of Reporting Persons Joseph Patrick Healey
2.	Check The Appropriate Box if a Member of a Group (See Instructions) (a) ¨         (b) ¨
3.	SEC Use Only
4.	Citizenship or Place of Organization United States

Number of Shares Beneficially Owned By Each Reporting Person With	5.	Sole Voting Power 0
	6.	Shared Voting Power 6,534,000⁽¹⁾
	7.	Sole Dispositive Power 0
	8.	Shared Dispositive Power 6,534,000⁽¹⁾

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 6,534,000⁽¹⁾
10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares	¨
11.	Percent of Class Represented By Amount in Row (9) 11.8%⁽²⁾
12.	Type of Reporting Person (See Instructions) IN

(1) Represents 5,534,000 Class A Shares held directly by HC Sponsor LLC and 1,000,000 Class A Shares held directly by the HC Affiliates.

Item 1(a).	Name of Issuer
	Hyperfine, Inc.
Item 1(b).	Address of the Issuer’s Principal Executive Offices
	351 New Whitfield Street Guilford, CT 06437
Item 2(a).	Names of Persons Filing
	This statement is filed on behalf of each of the following persons (collectively, the “Reporting Persons”): (i) HC Sponsor LLC (ii) HealthCor Group, LLC (iii) Arthur Bruce Cohen (iv) Joseph Patrick Healey
Item 2(b).	Address of the Principal Business Office, or if none, Residence:
	55 Hudson Yards, 28th Floor New York, NY 10001
Item 2(c).	Citizenship
	See responses to Item 4 on each cover page.
Item 2(d).	Title of Class of Securities
	Class A common stock
Item 2(e).	CUSIP Number
	44916K106
Item 3.	If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a(n):
	Not Applicable.

Item 4.

Ownership

(a) Amount beneficially owned:

See responses to Item 9 on each cover page.

(b) Percent of Class:
See responses to Item 11 on each cover page.

(c) Number of shares as to which the Reporting Person has:

(i) Sole power to vote or to direct the vote:

See responses to Item 5 on each cover page.

(ii) Shared power to vote or to direct the vote:

See responses to Item 6 on each cover page.

(iii) Sole power to dispose or to direct the disposition of:

See responses to Item 7 on each cover page.

(iv) Shared power to dispose or to direct the disposition of:

See responses to Item 8 on each cover page.

	HC Sponsor LLC (the “Sponsor”) directly holds 5,534,000 Class A Shares (the “Founder Shares”) and entities affiliated with the Sponsor (the “HC Affiliates”) directly hold 1,000,000 Class A Shares (the “PIPE Shares”). The Sponsor is managed by its manager, HealthCor Sponsor Investments LLC, which is managed by its manager, HealthCor Group, LLC, which also indirectly manages the HC Affiliates. Arthur Cohen and Joseph Healey are the controlling members of HealthCor Group, LLC. As such, Messrs. Cohen and Healey have voting and investment discretion with respect to the securities held by each of HC Sponsor LLC and the HC Affiliates but disclaim beneficial ownership of such securities. The filing of this Statement shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any securities covered by this Statement.
Item 5.	Ownership of Five Percent or Less of a Class
	Not Applicable.
Item 6.	Ownership of More than Five Percent on Behalf of Another Person
	Not Applicable.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company
	Not Applicable.
Item 8.	Identification and Classification of Members of the Group
	Not Applicable.
Item 9.	Notice of Dissolution of Group
	Not Applicable.
Item 10.	Certification
	Not Applicable.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 14, 2022

	HC Sponsor LLC

	By:	/s/ Christine Clarke
	Name:	Christine Clarke
	Title:	Authorized Signatory

	HealthCor Group, LLC

	By:	/s/ Christine Clarke
	Name:	Christine Clarke
	Title:	Authorized Signatory

	/s/ Arthur B. Cohen
	Arthur B. Cohen

	/s/ Joseph P. Healey
	Joseph P. Healey

EXHIBIT INDEX

Exhibit No.		Description
99.1		Joint Filing Agreement, dated as of February 14, 2022 by and among HC Sponsor LLC, HealthCor Group, LLC, Arthur B. Cohen and Joseph P. Healey

Exhibit 99.1

JOINT FILING AGREEMENT

This Joint Filing Agreement may be signed in counterparts with the same effect as if the signature on each counterpart were upon the same instrument.

	HC Sponsor LLC

	By:	/s/ Christine Clarke
	Name:	Christine Clarke
	Title:	Authorized Signatory

	HealthCor Group, LLC

	By:	/s/ Christine Clarke
	Name:	Christine Clarke
	Title:	Authorized Signatory

	/s/ Arthur B. Cohen
	Arthur B. Cohen

	/s/ Joseph P. Healey
	Joseph P. Healey

Get the next $HYPR alert in real time by email

Date

Price Target

Rating

Analyst

8/11/2022

$8.00 → $2.40

Overweight → Equal Weight

Wells Fargo

5/31/2022

$7.00

Outperform

Evercore ISI

4/14/2022

$8.00

Overweight

Wells Fargo

SEC Form SC 13G filed by Hyperfine Inc.

Crush Q3 2025 with the Best AI Executive Assistant

Recent Analyst Ratings for
$HYPR

SEC Form SC 13G filed by Hyperfine Inc.

Crush Q3 2025 with the Best AI Executive Assistant

Recent Analyst Ratings for
$HYPR

$HYPR
Press Releases

Fastest customizable press release news feed in the world

Hyperfine Announces Key Executive Appointments to Strengthen its Leadership Position in AI-Powered Portable MRI

Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality

Hyperfine Announces FDA Clearance of Optive AI™ Software, Introducing the Most Substantial Image Quality Improvement Ever for the Swoop® System

$HYPR
SEC Filings

SEC Form 8-K filed by Hyperfine Inc.

Hyperfine Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

SEC Form 424B5 filed by Hyperfine Inc.

$HYPR
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Hyperfine downgraded by Wells Fargo with a new price target

Evercore ISI initiated coverage on Hyperfine with a new price target

Wells Fargo initiated coverage on Hyperfine with a new price target

$HYPR
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

SEC Form 4 filed by Director Wolterman Dan

CFO and CAO Hale Brett was granted 300,000 shares (SEC Form 4)

Chief Operating Officer Teisseyre Thomas was granted 300,000 shares, increasing direct ownership by 365% to 382,213 units (SEC Form 4)

$HYPR
Leadership Updates

Live Leadership Updates

QuidelOrtho Announces Appointment of Two Independent Directors to its Board

Hyperfine Announces Strategic Leadership Additions to Drive Growth in Key Business Verticals

Hyperfine, Inc. Continues Global Market Expansion by Entering Into a Distribution Partnership with Radiosurgery Global, Ltd. to Bring the Swoop® System to India

$HYPR
Financials

Live finance-specific insights

Hyperfine, Inc. to Announce First Quarter 2025 Financial Results on May 13, 2025

Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

Hyperfine, Inc. Reports Third Quarter 2024 Financial Results

$HYPR
Large Ownership Changes

This live feed shows all institutional transactions in real time.